Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
UNIVERSITE DE PARIS has 3 pending office actions in Biotechnology & Pharmaceuticals. The record identifies 3 distinct examiners and 2 distinct art units, showing that the pending work is distributed across multiple examiners and technical examination settings.
DHARITHREESAN, NIDHI is the busiest examiner, with 1 pending action. Counsel should coordinate responses across the identified examiners while addressing the issues associated with each art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DHARITHREESAN, NIDHI | 1 | 40.0% | +33.1% |
| YU, TIAN NMN | 1 | 55.6% | +19.3% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.3% | +58.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614023 | METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF | GIAMMONA, FRANCESCA FILIPPA | 30d overdue |
| 17615912 | METHOD FOR DETERMINING AN OPTIMAL DRUG DOSING REGIMEN | DHARITHREESAN, NIDHI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17614023 | METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF | GIAMMONA, FRANCESCA FILIPPA | 30d overdue |
| 17615912 | METHOD FOR DETERMINING AN OPTIMAL DRUG DOSING REGIMEN | DHARITHREESAN, NIDHI | — |
| 17613990 | DIGITAL BIOMOLECULES DETECTION AND/OR QUANTIFICATION USING ISOTHERMAL AMPLIFICATION | YU, TIAN NMN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17615912 | METHOD FOR DETERMINING AN OPTIMAL DRUG DOSING REGIMEN | DHARITHREESAN, NIDHI | 1686 | §101§102§103§112Other | Non-Final OA | — | Pending | Dec 02, 2021 |
| 17613990 | DIGITAL BIOMOLECULES DETECTION AND/OR QUANTIFICATION USING ISOTHERMAL AMPLIFICATION | YU, TIAN NMN | 1681 | §103§112DP | Final Rejection | — | Pending | Nov 24, 2021 |
| 17614023 | METHOD OF DIGITAL MULTIPLEX DETECTION AND/OR QUANTIFICATION OF BIOMOLECULES AND USE THEREOF | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103§112 | Final Rejection | 30d overdue | Pending | Nov 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITE DE PARIS has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Nidhi Dharithreesan has the most, with 1 of UNIVERSITE DE PARIS's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
